Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

We partner with medical device manufacturers in the U.S. and abroad to bring revolutionary products to market, navigate industry regulations, protect designs, drive business growth, and enhance and execute overall business strategies. Our regulatory counsel team manages interactions with governmental agencies, including the Centers for Medicaid and Medicare Services and the Food and Drug Administration, and our government affairs professionals help to identify and mobilize strategies for prompt product approvals and to respond to the challenges and capitalize on the opportunities presented by new regulations and changes in the marketplace. Whether developing a new product, seeking to enter a new market or pursuing a strategic acquisition or affiliation, our regulatory, corporate, transactional and IP attorneys leverage industry-specific insights to help medical device companies advance their goals.

Insights & Events

Insights
Media Mentions February 2025

Tricia Beckmann Discusses Federal Oversight of Medicare Brokers With Law360

1 min read  
Media Mentions February 2025

Doriann Cain Provides Insight in Navigating HIPAA Compliance With Becker’s Hospital Review

1 min read  
Updates February 2025

Biden’s 11th-Hour Ethylene Oxide Decision Continues the Environmental Protection Agency’s Expansion Into Occupational Safety

But Will It Stick?
5 min read  
Updates February 2025

China Issues Final Compliance Guidelines in Regulating the Medical Industry

Compliance Guidelines on Preventing Commercial Bribery Risks for Pharmaceutical Enterprises
7 min read  
Updates December 2024

Five Major Drug & Medical Device Developments of 2024

13 min read  
Updates December 2024

The Prospects of Dr. Martin Makary and RFK Jr. at HHS, Potential Pharma Tariffs, and EU Guidance on Ethylene Oxide

Biopharma & Medical Devices Briefing
7 min read  
Media Mentions December 2024

Tricia Beckmann Comments on CMS Rule Aimed at Defining Coverage Criteria, AI-Driven Tools

1 min read  
Updates October 2024

Biopharma & Medical Device Briefing: PFAS Reporting Requirements; ECHA Substances of Very High Concern List; and MicroRNA Discovery Wins Nobel Prize

4 min read  
Updates September 2024

Biopharma & Medical Devices Briefing: LLMs in Health Care; Nitrosamine in Pharma; PFAS; and CDER’s Quantitative Medicine Center of Excellence

5 min read  
Updates September 2024

Fast-Approaching Extended Producer Responsibility (EPR) Deadlines: Colorado’s EPR Requirements and Registration

8 min read